Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2016 1
2017 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

3 results
Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Development of interventions for the secondary prevention of Alzheimer's dementia: the European Prevention of Alzheimer's Dementia (EPAD) project.
Ritchie CW, Molinuevo JL, Truyen L, Satlin A, Van der Geyten S, Lovestone S; European Prevention of Alzheimer's Dementia (EPAD) Consortium. Ritchie CW, et al. Lancet Psychiatry. 2016 Feb;3(2):179-86. doi: 10.1016/S2215-0366(15)00454-X. Epub 2015 Dec 10. Lancet Psychiatry. 2016. PMID: 26683239 Review.
Interventions that either modify risk or reduce the development of early disease could delay the onset of dementia or reduce the rate of cognitive and functional decline. The European Prevention of Alzheimer's Dementia
Interventions that either modify risk or reduce the development of early disease could delay the onset of dementia
European Prevention of Alzheimer's Dementia Longitudinal Cohort Study (EPAD LCS): study protocol.
Solomon A, Kivipelto M, Molinuevo JL, Tom B, Ritchie CW; EPAD Consortium. Solomon A, et al. BMJ Open. 2019 Feb 19;8(12):e021017. doi: 10.1136/bmjopen-2017-021017. BMJ Open. 2019. PMID: 30782589 Free PMC article.
INTRODUCTION: The European Prevention of Alzheimer's Dementia (EPAD) project is funded initially by the Innovative Medicines Initiative and has been established to overcome the major hurdles hampering drug development for …
INTRODUCTION: The European Prevention of Alzheimer's Dementia (EPAD) project is funded init …
Ethical Issues in the Development of Readiness Cohorts in Alzheimer's Disease Research.
Milne R, Bunnik E, Tromp K, Bemelmans S, Badger S, Gove D, Maman M, Schermer M, Truyen L, Brayne C, Richard E. Milne R, et al. J Prev Alzheimers Dis. 2017;4(2):125-131. doi: 10.14283/jpad.2017.5. J Prev Alzheimers Dis. 2017. PMID: 29186282
There is growing interest in the development of novel approaches to secondary prevention trials in Alzheimer's disease to facilitate screening and recruitment of research participants and to reduce the time and costs associated with clini …
There is growing interest in the development of novel approaches to secondary prevention trials in Alzheimer' …